Regorafenib plus nivolumab as first-line therapy for unresectable hepatocellular carcinoma (uHCC): multi-center phase 2 trial (RENOBATE).
Nivolumab;Regorafenib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Regorafenib plus nivolumab as first-line therapy for unresectable hepatocellular carcinoma (uHCC): multi-center phase 2 trial (RENOBATE). ### Output: Nivolumab;Regorafenib